SBMFF fundamentals
An in-depth look to Sino Biopharmaceutical Ltd. operating, investing, and financing activities
SBMFF free cash flow for H2 23 is 457.72 M USD. For 2023, SBMFF free cash flow was 752.11 M USD and operating cash flow was 935.59 M USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM